Erratum: Novel molecular hybrids of n-benzylpiperidine and 1,3,4-oxadiazole as multitargeted therapeutics to treat alzheimer's disease (ACS Chemical Neuroscience (2019) 10:10 (4361-4384) DOI: 10.1021/acschemneuro.9b00430)

  • Piyoosh Sharma
  • , Avanish Tripathi
  • , Prabhash Nath Tripathi
  • , Saumitra Sen Singh
  • , Surya Pratap Singh
  • , Sushant Kumar Shrivastava

Research output: Contribution to journalComment/debate

3 Scopus citations

Abstract

An issue pertaining to a misplaced image (Figure 3D, Aβ Day 10 sample) during figure preparation in our previously published article has been rectified along-with the necessary text to ensure the correctness of the scientific record. Apologies for the inadvertent human error. The corrected version of Figure 3D (Aβ Day 10 sample) is as follows: (Figure Presented).

Original languageEnglish
Pages (from-to)2782
Number of pages1
JournalACS Chemical Neuroscience
Volume11
Issue number17
DOIs
StatePublished - Sep 2 2020

Fingerprint

Dive into the research topics of 'Erratum: Novel molecular hybrids of n-benzylpiperidine and 1,3,4-oxadiazole as multitargeted therapeutics to treat alzheimer's disease (ACS Chemical Neuroscience (2019) 10:10 (4361-4384) DOI: 10.1021/acschemneuro.9b00430)'. Together they form a unique fingerprint.

Cite this